Literature DB >> 20963642

Failure of vitamin supplementation to lower the risk of recurrent stroke.

Harold P Adams1.   

Abstract

Entities:  

Year:  2011        PMID： 20963642     DOI： 10.1007/s11910-010-0152-0

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  23 in total

1.  Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction.

Authors:  Frank M Faraci; Steven R Lentz
Journal:  Stroke       Date:  2004-02       Impact factor: 7.914

2.  Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.

Authors:  Jane M Armitage; Louise Bowman; Robert J Clarke; Karl Wallendszus; Richard Bulbulia; Kazem Rahimi; Richard Haynes; Sarah Parish; Peter Sleight; Richard Peto; Rory Collins
Journal:  JAMA       Date:  2010-06-23       Impact factor: 56.272

3.  Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke.

Authors:  J W Eikelboom; G J Hankey; S S Anand; E Lofthouse; N Staples; R I Baker
Journal:  Stroke       Date:  2000-05       Impact factor: 7.914

4.  Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials.

Authors:  M Ebbing; K H Bønaa; E Arnesen; P M Ueland; J E Nordrehaug; K Rasmussen; I Njølstad; D W Nilsen; H Refsum; A Tverdal; S E Vollset; H Schirmer; Ø Bleie; T Steigen; Ø Midttun; A Fredriksen; E R Pedersen; O Nygård
Journal:  J Intern Med       Date:  2010-10       Impact factor: 8.989

Review 5.  Homocysteine and atherothrombosis.

Authors:  E Falk; J Zhou; J Møller
Journal:  Lipids       Date:  2001       Impact factor: 1.880

6.  Homocysteine lowering with folic acid and B vitamins in vascular disease.

Authors:  Eva Lonn; Salim Yusuf; Malcolm J Arnold; Patrick Sheridan; Janice Pogue; Mary Micks; Matthew J McQueen; Jeffrey Probstfield; George Fodor; Claes Held; Jacques Genest
Journal:  N Engl J Med       Date:  2006-03-12       Impact factor: 91.245

7.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Authors:  James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

8.  Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.

Authors:  Christine M Albert; Nancy R Cook; J Michael Gaziano; Elaine Zaharris; Jean MacFadyen; Eleanor Danielson; Julie E Buring; JoAnn E Manson
Journal:  JAMA       Date:  2008-05-07       Impact factor: 56.272

9.  Secondary prevention with folic acid: effects on clinical outcomes.

Authors:  Anho Liem; Giny H Reynierse-Buitenwerf; Aeilko H Zwinderman; J Wouter Jukema; Dirk J van Veldhuisen
Journal:  J Am Coll Cardiol       Date:  2003-06-18       Impact factor: 24.094

Review 10.  The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis.

Authors:  Kathleen Potter; Graeme J Hankey; Daniel J Green; John Eikelboom; Konrad Jamrozik; Leonard F Arnolda
Journal:  BMC Cardiovasc Disord       Date:  2008-09-20       Impact factor: 2.298
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.